04:18 PM EDT, 10/30/2024 (MT Newswires) -- Amgen ( AMGN ) reported Q3 non-GAAP earnings late Wednesday of $5.58 per diluted share, up from $4.96 a year earlier.

Analysts polled by Capital IQ expected $5.11.

Revenue for the quarter that ended Sept. 30 was $8.50 billion, up from $6.90 billion a year earlier.

Analysts surveyed by Capital IQ expected $8.50 billion.

The company now expects 2024 non-GAAP earnings of $19.20 to $20 per diluted share. Analysts surveyed by Capital IQ expect $19.51. The company previously expected $19.10 to $20.10.

The company expects revenue for the full year of $33 billion to $33.8 billion. Analysts polled by Capital IQ expect $33.20 billion. The company previously expected $32.8 billion to $33.8 billion.